文档详情

the expression of baff, april and tweak is altered in eczema skin but not in the circulation of atopic and seborrheic eczema patients高飞球的一击的表达,4月和调整在湿疹的皮肤改变,但不是在过敏性和皮脂溢性湿疹患者的循环.pdf

发布:2017-09-08约6.38万字共10页下载文档
文本预览下载声明
The Expression of BAFF, APRIL and TWEAK Is Altered in Eczema Skin but Not in the Circulation of Atopic and Seborrheic Eczema Patients 1 1 1 2 2 Yunying Chen *, Sara Lind Enoksson , Catharina Johansson , Maria A. Karlsson , Lena Lundeberg , Gunnar Nilsson3, Annika Scheynius1., Mikael C. I. Karlsson1. 1 Clinical Allergy Research Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden, 2 Dermatology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden, 3 Clinical Immunology and Allergy Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden Abstract The TNF family cytokines BAFF (B-cell activating factor of the TNF family) and APRIL (a proliferation-inducing ligand) are crucial survival factors for B-cell development and activation. B-cell directed treatments have been shown to improve atopic eczema (AE), suggesting the involvement of these cytokines in the pathogenesis of AE. We therefore analyzed the expression of these TNF cytokines in AE, seborrheic eczema (SE) and healthy controls (HC). The serum/plasma concentration of BAFF, APRIL and a close TNF member TWEAK (TNF-like weak inducer of apoptosis) was measured by ELISA. The expression of these cytokines and their receptors in skin was analyzed by quantitative RT-PCR and immunofluorescence. Unlike other inflammatory diseases including autoimmune diseases and asthma, the circulating levels of BAFF, APRIL and TWEAK were not elevated in AE or SE patients compared with HCs and did not correlate with the disease severity or systemic IgE le
显示全部
相似文档